Researchers developed knitted textiles that can function as switches and count steps. A piece of knitted fabric can now do more than stretch and fold. By carefully controlling its yarns and stitch patterns, researchers have made textiles that snap between stable shapes, operate electrical switches, and even track a person’s steps. Researchers at the Harvard […]
Harvard Researchers Turn Ordinary Knitting Into Programmable Technology
Researchers developed knitted textiles that can function as switches and count steps. A piece of knitted fabric can now do more than stretch and fold. By carefully controlling its yarns and stitch patterns, researchers have made textiles that snap between stable shapes, operate electrical switches, and even track a person’s steps. Researchers at the Harvard […]
Chemists Defy Decades-Old Rules With “Free Electron” Breakthrough
Free electrons offer chemists a new way to control reactions that conventional electron transfer rules would normally prevent. Inside a reaction flask, an electron can determine which molecules combine and which remain unchanged. Chemists rely on this control to build complex compounds used in lifesaving drugs, advanced materials, and laboratory models of biological systems. One […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]